Best Brain MRI diagnosticians in Turkey: TOP 75 doctors

Medical Area of Interest and Activities 

Epilepsy, Febrile Convulsions 

Cerebral Palsy and Neurological Development Disorder 

Neurometabolic and Neurodegenerative Diseases 

Acquired Neurodegenerative Diseases (Subacute Sclerosing Panencephalitis, Autoimmune Encephalitis etc.)

Education 

Hacettepe University Trabzon Faculty of Medicine 

Hacettepe University Faculty of Medicine İhsan Doğramacı Pediatric Hospital, Department of Pediatrics (Residency Training) 

Hacettepe University Faculty of Medicine İhsan Doğramacı Pediatric Hospital, Department of Pediatric Neurology (Minor Residency Training)

Experience 

Liv Hospital Ulus 

Hacettepe University Faculty of Medicine İhsan Doğramacı Hospital, Ankara 1981-1986 

SSI Yenişehir Dispensary, Pediatrics Specialist (Compulsory Service), Ankara 1986-1991 

Hacettepe University Faculty of Medicine İhsan Doğramacı Hospital Pediatric Neurology Minor Assistant, Ankara 1991-1993 

Ankara Pediatric Health, Diseases and Hematology Oncology Hospital, Pediatric Neurology Department Establishment and Specialist, Ankara. 1993-1999 

Ankara Pediatric Health, Diseases and Hematology Oncology Hospital, Assoc.Prof.Dr., Clinic Chief, Pediatric Neurology Department and Infant Service Supervisor, Ankara. 1999-2012 

Health Sciences University Şişli Hamidiye Etfal Research and Training Hospital, Assoc.Prof.Dr. Lecturer, Infant Service Supervisor and Pediatric Neurologist, Istanbul. 2012

Memberships 

1991: Turkish Society of Pediatric Neurology 

1994: Turkish Chapter of International League Against Epilepsy 

1995: Society of Asian and Oceanian Pediatric Neurology 

1996: Society of European Pediatric Neurology 

1996: Society of World Pediatric Neurology 

2007: Turkish Society of Developmental Pediatric Neurology (Founder Member)

Dr. Türe developed a step-wise teaching method for utilizing the microscope and suction tube. He then presented this technique to the neurosurgical community by teaching neurosurgeons and visiting laboratories internationally. He was also President of the WFNS 16th World Congress of Neurosurgery in Istanbul, Turkey in 2017.

Specialization: Neurospinal Cord and Nerve Surgery

Foreign Language : English

Date of Birth: 03.02.1974

Education :

Gazi University Faculty of Medicine (1991-1997)
Fırat University Neurosurgery Specialization (1999-2004)

Experience:

Private Adatip Hospital (2004-2013)
Private Cihan Hospital (2013-2015)
Private Adatip Hospital (2015-...)

Memberships:

Sakarya Medical Chamber
Turkish Neurosurgery Association

Assoc. Prof.  Nesrin Helvacı Yılmaz graduated from Hacettepe University in 2000 as a Medical Doctor.  She completed her specialty training in the Department of Neurology at Ankara University in 2006.

She started her compulsory service in Mardin Nusaybin State Hospital in 2007.  Nesrin Helvacı Yılmaz continued her duty in Gaziantep 27 December State Hospital in 2008.  She worked as a neurologist at Biophysis Nilüfer Medical Center and Ali Osman Sönmez Oncology Hospital in Bursa between 2010-2011, and at Istanbul Universal Aksaray Hospital between 2011-2012. From October 2012, she started to work as a Doctor Lecturer in Istanbul Medipol University Neurology Department.  Nesrin Helvacı Yılmaz received the title of associate professor in 2021.  In 2015, she worked as an Honorary Observer in Parkinson's Disease and Deep Brain Stimulation (Neuromodulation) at UCL Queen Square Institute of Neurology, National Hospital for Neurology in London.  She took part in many training programs on Deep Brain Stimulation (Neuromodulation) in Turkey and abroad between 2013-2022.

Regarding her speciality in Parkinson's disease and movement disorders, she has 5 Tubitak projects, a 2-chapter book , 30 clinical researches and 80 reports presented in domestic and abroad. Assoc. Prof. Nesrin Helvacı Yılmaz, who is still working within the staff of Medipol University, managed the Parkinson's and Movement Disorders Unit of the Department of Neurology during her working time and plans Deep Brain Stimulation therapy applications with the neurosurgical team.

Since September 2018, she has been working as a coordinator for student education in the 5th semester of Neurology. As of December 2022, she has developed treatment plans for patients at Medipol University Istanbul Parkinson's Disease and Movement Disorders Center (PARMER) and provides the most appropriate personal medical follow-up and treatment support for each patient.

PUBLICATIONS

1-Yilmaz N, Yigit A, Akbostanci MC. Clozapine induced epilepsy. Revue Neurologique 2004, Nov;160/11:1093.

2-Nesrin Helvacı Yılmaz, Nursel Aydın. Sıcak Su Epilepsili Bir Olgu. Türkiye Klinikleri Nöroloji Dergisi 2004/Cilt2/Sayı 2.

3-Nesrin Helvacı Yılmaz, Nursel Aydın. Refleks Epilepsiler. Türkiye Klinikleri Nöroloji Dergisi 2004/Cilt2/Sayı 2.

4-Mine Hayriye Sorgun, Bilge Koçer, Funda Kaplan, Nesrin Yılmaz, Nezih Yücemen, Canan Yücesan. Multipl Sklerozda Kraniyal Nöropati. Turk Norol Derg 2011;17:137-142.

5-Nesrin Helvacı Yılmaz, Gökçen Duymaz, Mehmet Akif Yaşar. Parkinson Hastalığı Olan Bir Olguda Malign Sendrom. Turk Norol Derg 2012:18;123-125.

6-Yilmaz NH, Akbostanci MC, Oto A, Aykac O. Prevalence of restless legs syndrome in Ankara, Turkey: an analysis of diagnostic criteria and awareness. Acta Neurol Belg 2012 Oct 31. [Epub ahead of print].

7-Yılmaz NH, Bingol AP. Sensitivity and specificity of Ankara University Cerebral Dominance Inventory in comparison with the Wada test. Acta Neurol Belg 2013 Jun 6 [Epub ahead of print].

8-Sema Demirci, Nesrin Helvacı Yılmaz, Efsun Şenocak, Fatih Han Bölükbaşı. Pons Kavernomu: Kranial Manyetik Rezonans Görüntüleme Bulguları. Turk Norol Derg 2012:19:72.

9-Nesrin Helvacı Yılmaz, Sinem Atik Güngör, Taflan Sahlepçi. Küçük hücreli akciğer kanseri tedavisinde cisplatin kullanımı sırasında gelişen akut iskemik inme: olgu sunumu. J Kartal TR. Baskıdaki Makaleler: KEAH-26937.

POSTERLER:

-Serebral venöz tromboz ve bruselloz Birlikteliği; Olgu Sunumu (42. Ulusal Nöroloji Kongresi-Antalya 2006)

-Waldenström makroglobulinemisine eşlik eden epileptik nöbetler ve nonkonvülsif status epileptikus (42. Ulusal Nöroloji Kongresi-Antalya 2006)

-Prevalence of Restless Legs Syndrome in Ankara, Turkey (16. Uluslararası Parkinson ve Hareket Bozuklukları Kongresi-Dublin 2012).

-Konjenital Miyastenik Sendrom (29. Ulusal Nörofizyoloji EEG-EMG Kongresi- Antalya 2013).

-Beşinci haftada duyusal iletimleri normal olan bir enjeksiyon nöropatisi olgusu (29. Ulusal Nörofizyoloji EEG-EMG Kongresi- Antalya 2013).

-Olgu sunumu: Mononöritis mültipleks ve lepra (29. Ulusal Nörofizyoloji EEG-EMG Kongresi- Antalya 2013).

-İdyopatik Parkinson Hastalığı’nda hızlanmış unutma ve uyku kalitesi (10. Ulusal Parkinson ve Hareket Bozuklukları Kongresi-Antalya 2013).

-Hiperglisemiye bağlı hemikore ve bazal gangliyon hiperintensitesi: Olgu sunumu (10. Ulusal Parkinson ve Hareket Bozuklukları Kongresi-Antalya 2013).

Assoc. Prof.  Nesrin Helvacı Yılmaz graduated from Hacettepe University in 2000 as a Medical Doctor.  She completed her specialty training in the Department of Neurology at Ankara University in 2006.

She started her compulsory service in Mardin Nusaybin State Hospital in 2007.  Nesrin Helvacı Yılmaz continued her duty in Gaziantep 27 December State Hospital in 2008.  She worked as a neurologist at Biophysis Nilüfer Medical Center and Ali Osman Sönmez Oncology Hospital in Bursa between 2010-2011, and at Istanbul Universal Aksaray Hospital between 2011-2012. From October 2012, she started to work as a Doctor Lecturer in Istanbul Medipol University Neurology Department.  Nesrin Helvacı Yılmaz received the title of associate professor in 2021.  In 2015, she worked as an Honorary Observer in Parkinson's Disease and Deep Brain Stimulation (Neuromodulation) at UCL Queen Square Institute of Neurology, National Hospital for Neurology in London.  She took part in many training programs on Deep Brain Stimulation (Neuromodulation) in Turkey and abroad between 2013-2022.

Since September 2018, she has been working as a coordinator for student education in the 5th semester of Neurology. As of December 2022, she has developed treatment plans for patients at Medipol University Istanbul Parkinson's Disease and Movement Disorders Center (PARMER) and provides each patient the most appropriate personal medical follow-up and treatment support.

Education:

Medical Specialization

Hacettepe University 2017 - 2007

Medical Specialization (Minor)

Ufuk University 2011 - 2009

Doctorate

Ankara University 2021 - 2000

Undergraduate

Ankara University 2006

Experience: 

Research Assistant

Biotechnology Department, Biotechnology Institute, Ankara University

September 01, 2009 - October 08, 2021

Research Assistant

Department of Pediatrics, Faculty of Medicine, Hacettepe University

February 27, 2014 - February 28, 2017

Research Assistant

Dr. Ridvan Ege Health Research and Application Center, Ufuk University

November 27, 2007 - December 09, 2011

Medical School: Suleyman Demirel University, 2004

Neurosurgery Training: Gazi University, Department of Neurosurgery, 2011

Dr Mehmet Tonge has international and nationwide 32 publications, 12 book chapters, 92 oral and poster presentations and 41 invited lectures, mostly on Stereotactic and Functional Neurosurgery.

Work & Training experience:

2004-2011: Gazi University, Department of Neurosurgery (Residency)

2008: Zurich University Hospital, Department of Neurosurgery (Intraoperative MRI applications), Switzerland

2008: Zurich University Hospital, Department of Neurosurgery: Microneurosurgery, white matter dissection, interventional neuroradiology courses, Switzerland

2011 – 2012: Sinop Ataturk State Hospital, Neurosurgeon

2012 – 2013: Cankiri State Hospital, Neurosurgeon

2013 – 2014: Istanbul Medipol University, Department of Neurosurgery & Gamma Knife Center (Ass Prof)

2013 – now: Maastricht University Neurosurgery & Neuroscience Department (Visiting scientist, PhDc) The Netherlands

2014: Maastricht University, The Netherlands: Deep Brain Stimulation Fellowship 2014-2018: Istanbul Memorial Hospital Neurosurgery: Staff Neurosurgeon

2016-2018: Istanbul Florence Nightingale Hospital (Consultant, Gamma Knife Center)

2018-now: Istanbul Medipol University (Stereotactic & Functional Neurosurgery, Gamma Knife Center) Ass. Prof.)

Dr Mehmet Tonge has completed 4-year cycle EANS (European Association of Neurosurgical Societies) Training courses.

Clinical areas of interest:

• Stereotactic & Functional Neurosurgery

• Surgery for movement disorders

• Gamma Knife Radiosurgery

* Surgery for pain & spasticity

* Psychosurgery

Research areas of interest:

* Deep brain stimulation

• Stereotactic radiosurgery

Dr. Başak Bolluk Kılıç, MD graduated from Ankara University Faculty of Medicine in 2000 as a Medical Doctor.  She completed her specialization training in the Department of Neurology at Ankara University in 2005.

In 2004, she worked as an observer at the Department of Movement Disorders at the University of Barcelona Medical Faculty.  Having started her compulsory service in Kırşehir State Hospital in 2006, Dr.  Başak Bolluk Kılıç, MD worked at Ankara Private Tandoğan Magnet Hospital in 2008, at Çamlıca Erdem Hospital between 2010-2016, at Bilgi University Electroneurophysiology Department between 2013-2017, at Bahçeşehir University Faculty of Medicine between 2017-2018 and at Medical Park between 2016-2018. She worked as an Assistant Professor at Göztepe Hospital.

In September 2018, at Istanbul Medipol University Parkinson's Disease and Movement Disorders Center (PARMER) she created the patients' treatment plans. She provides each patient with the most appropriate personalized medical follow-up and treatment support.

Experience

2019 – 2019

• University of Insubria, Varese, Italy, 

Insubria University Faculty of Medicine

2015

• MERSİN UNIVERSITY/FACULTY OF MEDICINE, DOCTOR, LECTURER

2013 – 2015

• ANKARA PRIVATE ACIBADEM HOSPITAL

2010 – 2012

• DIYARBAKIR TRAINING AND RESEARCH HOSPITAL,

2002 – 2003

• AYDIN 1ST PRIVATE TRAINING BATTALION
•  

Education

2010

• ANKARA UNIVERSITY FACULTY OF MEDICINE, BRAIN AND SURGERY SPECIALIST

1992

• GAZI UNIVERSITY, FACULTY OF MEDICINE

PROFESSIONAL EXPERIENCE

2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine

2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine

06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine

10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship

2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship

2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist

2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.

EDUCATION

2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.

2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

INTERNATIONAL CLINICAL TRIALS:

1. Astefania - ROCHE

• Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
• Role: Subinvestigator

2. PFİZER

• Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
• Role: Subinvestigator

3. RECITE - AMGEN

• Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
• Role: Subinvestigator

4. NAVIGATE - BAYER

• Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
• Role: Subinvestigator

5. RUBY - Tesaro (PRA)

• Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
• Role: Subinvestigator

6. ENGOT-ov43/GOG-3036 - MSD

• Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
• Role: Subinvestigator

7. ASTRA ZENECA

• Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
• Role: Subinvestigator

8. ROSY-O - ASTRA ZENECA

• Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
• Role: Subinvestigator
•  

INTERNATIONAL PUBLICATIONS

I. Published journal articles indexed by SCI, SSCI, and AHCI

Weekly Paclitaxel in Classic Kaposi Sarcoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
• Journal: Medicine, 102(5)

Carboplatin Desensitization in Ovarian Carcinoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
• Journal: Medicine, 101(45), e31726

High-Dose Chemotherapy for Ewing’s Sarcoma

• Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
• Journal: Medicine, 101(49), e32213

Multidrug Refractory TFE3(+) Renal Cell Carcinoma

• Authors: Paksoy, Nail, et al.
• Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

Crizotinib Efficacy in NSCLC with MET Alterations

• Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
• Journal: Medicine, 101(50), e32368

Clinicopathological Features in ALK Mutant NSCLC

• Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
• Journal: Medicine, 101(34)

PSMA-Based Tumor Burden in Prostate Cancer

• Authors: HAS SIMSEK, Duygu, et al.
• Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

Atezolizumab in Metastatic Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: European Urology Focus, 2021, 7.5: 1061-1066

Pulmonary Sarcomatoid Carcinoma

• Authors: FERHATOGLU, Ferhat, et al.
• Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

Atezolizumab with Chemotherapy in Small Cell Lung Cancer

• Authors: GÜRBÜZ, Mustafa, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

• Authors: AY, Seval, et al.
• Journal: Journal of Chemotherapy, 2022, 1-7

Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

• Authors: CIL, Ibrahim, et al.
• Journal: Tumori Journal, 2022, 108.1: 19-25

Real-Life Efficacy of Osimertinib in Advanced NSCLC

• Authors: HIZAL, Mutlu, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

ALK-Positive Cells Percentage and Alectinib Efficacy

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
• Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

Real-World Data on Alectinib in ALK-Positive NSCLC

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
• Journal: Future Oncology, 18(23), 2573-2582

Prognostic Factors in Metastatic RCC with T790M Mutation

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

• Authors: DEMIR, Semra, et al.
• Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

• Authors: ÖZDEMIR, Seçil Kepil, et al.
• Journal: Allergy, 2019, 74.6: 1187-1190

Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

• Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
• Journal: The Oncologist, oyad257

Subsequent Treatments in Hormone-Positive Breast Cancer Progression

• Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
• Journal: BMC cancer, 23(1), 192

Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
• Journal: Scientific Reports, 13(1), 8779

Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
• Journal: Journal of Cancer Research and Clinical Oncology, 1-9

Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

• Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
• Journal: European Journal of Breast Health, 19(2), 128

Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

• Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
• Journal: Future Oncology, 19(10), 727-736

Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

• Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
• Journal: [Not specified]

Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

• Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
• Journal: Medicine, 102(39), e35383

Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

• Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
• Journal: Medicine, 102(41), e35245

Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

Thesis:

Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

• Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

• Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

• Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

Efficacy of temozolomide in pretreated patients with metastatic sarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

• Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

• Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

• Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

• Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

• Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

Education

2019

Istanbul Faculty of Medicine, Electroneurophysiology

2005

Istanbul University Cerrahpasa Faculty of Medicine, Neurology

1998

Istanbul University Cerrahpasa, Faculty of Medicine

Experience

2017 - 2019

Private Adatip Kurtkoy Hospital

2016

TND – Schering-Plough Proceedings of the Year Awards

2015 - 2017

Istanbul Yeni Yüzyıl University Private Gaziosmanpaşa Hospital

2015 - 2015

Şişli Hamidiye Etfal Training and Research Hospital

2005 - 2014

Private Avicenna Hope Hospital

2015 – 2019 Istanbul University Cerrahpasa Faculty of Medicine

2019 – Medipol University Pendik Hospital

Publications

1- Yüz Ağrılarında Trigeminal SEP Uygulaması ; Yüksek Lisans Tezi

2- Glial Tümörlerde P53 , PTEN ve EGRF Pozitifliğinin İmmunohistokimyasal ; Uzmanlık Tezi

3- Two siblings with homocystinuria presenting with dystonia and parkinsonism

4- Lack of association between IL-1ß/? gene polymorphisms and temporal lobe epilepsy with hippocampal sclerosis

5- Psychogenic movement disorders in two children

6- Temporal Lob Epilepsi ve Hippokampal Sklerozlu Hastalarda İnterlökin 1-ß ve İnterlökin 1-? Gen Polimorfizminin Analizi

7- Hippokampal Skleroza Bağlı Mesial Temporal Lob Epilepsisi İle İnterlökin 1-ß ve İnterlökin 1-? Gen Polimorfizmi İlişkisinin Araştırılması

Trustworthy, attentive, successful neurosurgeon with over 34 years of experience, high rate of success and exceptional surgical skills, providing quality neurological service for patients, successfully treating over thousands of patients suffering from many severe, complex conditions of the brain, spine and the nerves. 

Experienced in performing treatment modalities like micro neurosurgery, endoscopic skull base surgery, endoscopic third ventriculostomy, minimally invasive spine surgery and percutaneous spine surgery. Keen on performing clinical research and attending national and international medical conferences to stay abreast of new technologies in the field. Compassionate and detail-oriented with excellent communication skills. Expertise in healthcare, education and program management. Adept at developing and implementing forward-thinking strategies to enhance patient outcomes and collective knowledge in the field. Desiring to bring skills and success. Focused on working closely with other medical professionals and following up with patients. Well-versed at emergency procedures and fast and accurate sanitation.

Work History

2020-01 – Current - Asst. Prof. Neurosurgeon

Istanbul Medipol University, Health Care Practice and Research Center Pendik Hospital

• He successfully treated and followed patients with cerebral hemorrhage, brain and spinal cord tumors, and patients with hydrocephalus.

• He performed transnasal pituitary surgeries with success.

• Also, many cervical lumbar and thoracic disc patients were successfully treated, and disc prosthesis were applied to some of them.

• He re-operated a degenerative spine patient who had been operated on before at another center and the patient regained his health.

• He also successfully treated patients with premature neonatal intracerebral hemorrhage.

2019-08 – 2020-01 - Neurosurgeon

Freelancer, Istanbul, Turkey

• Operated on patients' brains, spines and peripheral nerves to correct deformities, repair injuries, prevent and treat diseases and improve patients' motor functions. Performed successful operations for complex, advanced and complicated disease of the brain and spine some of which were operated unsuccessfully at other medical centers by different neurosurgeons.

• Offered advanced knowledge, leadership abilities and technical assistance with complex surgical cases.

• Maintained admitting privileges at local hospitals and provided quality follow-up care.

• Educated patients on recovery methods and times.

• Designed treatment plans for patients.

• Thoroughly assessed patients to identify medical condition and level of surgical risk.

• Founded a spinal surgery group with orthopedic surgeons and treated very advanced and severe vertebra deformities, spine abnormalities, scoliosis.

2018-12 - 2019-08 - Neurosurgeon

Alkafeel Super Speciality Hospital, Karbala, Iraq

• Conducted up to 5 operations per month to correct deformities in neurological and spinal systems, repair traumas, and treat diseases of different areas. Performed successful operations (success rate 100 percent : 90-95) for severe, complex and advanced diseases of the brain, spine and nerves in adults and children. (Cerebral intrinsic and extrinsic tumor surgery, posterior fossa surgery, spontaneous and traumatic intracranial hematomas, Interhemispheric 3th ventricle and lateral ventricle surgery, pontocerebellar angle tumor surgery, spinal instrumentation and fusion surgery, microdiscectomy cervical, thoracic, lumbar, pediatric cranial and spine anomaly surgery). Followed the patients postoperatively.

• Educated patients on recovery methods and times.

• Thoroughly assessed patients to identify medical condition and level of surgical risk.

• Performed emergency surgeries.

• Examined 900 patients in total in the outpatient clinic and gave medical treatments to them when necessary.

2015-10 - 2018-11 - Neurosurgeon

Medistate Kavacık Hospital, Istanbul, Turkey

• Operated on patients' brains, spines and peripheral nerves to correct deformities, repair injuries, prevent and treat different advanced, complex severe diseases and improve patients' motor functions.

• Conducted up to operations per month to correct deformities in neurological and spinal systems, repair traumas, restore partial or full functionality and prevent and treat diseases of different areas. 

• Performed successful operations (success rate percent : 95) for severe, complex and advanced diseases of the brain , spine and nerves in adults and children.(Brain tumor, arachnoid cyst, intracerebral hematoma, spinal stenosis, hydrocephalus, myelomeningocele).Followed the patients postoperatively. 

• Educated patients on recovery methods and times Thoroughly assessed patients to identify medical condition and level of surgical risk.

• Performed emergency surgeries (intracerebral hematoma, intracerebral abscess).

• Examined 850 patients in total in the outpatient clinic and gave medical treatment to them when necessary.

1994-03 - 2015-09 - Neurosurgeon

Ankara Training and Research Hospital, Ankara, Turkey

• Supervised trainees, medical students, residents and fellows to help each achieve proficiency in field.

• Conducted up to 20 operations per month to correct deformities in neurological and spinal systems, repair traumas, restore partial or full functionality and prevent and treat diseases of different areas. Performed successful operations (success rate: %90) for severe, complex and advanced diseases of the brain, spine and nerves in adults and children. (Skull base surgery, extended trans base approach, orbit zygomatic approach, presigmoid approach, orbital approaches, transcranial and lateral orbitotomy, Endoscopic transsphenoidal pituitary surgery, CSF leakage surgery, endoscopic, microscopic and transsphenoidal, transcranial. Endoscopic third ventriculostomy and surgery of multiloculated hydrocephalus and pediatric neurosurgery. Cerebral intrinsic and extrinsic tumor surgery, posterior fossa surgery. Brain aneurysm, AVM and cavernoma surgery.

• Spontaneous and traumatic intracranial hematomas. Hemifacial spasm and trigeminal neuralgia surgery (microsurgical decompression) Interhemispheric 3th ventricle and lateral ventricle surgery. Pineal area surgery. Pontocerebellar angle tumor surgery.

• Foreman magnum tumors surgery. Surgery of hydrocephaly, Syringomyelia and craniovertebral animalia).Followed the patients postoperatively.

• Educated patients on recovery methods and times Thoroughly assessed patients to identify medical condition and level of surgical risk.

• Performed emergency surgeries (Epidural, subdural and intracerebral hematoma, vertebra fracture).

• Examined 500-700 patients per day in the outpatient clinic and gave medical treatment to them when necessary. Examined patients in the emergency service.

• Designed treatment plans for patients.

• Offered advanced knowledge, leadership abilities and technical assistance with complex surgical cases.

• Led and oversaw 15 medical personnel in operating room setting to perform surgeries.

• Led and oversaw medical personnel in operating room setting to perform surgeries.

Education

1982-09 - 1988-08

M.D.: Medicine And (Pre-Medicine)

Ankara University Medical School - Ankara

General Medicine Training for 6 years. Graduated with a high GPA.

1988-11 - 1994-05

Specialist Neurosurgery: Neuroscience

University of Health Sciences - Ankara

6 years of neurosurgery training.

• My thesis was on brain abscess and their clinical and laboratory evaluations

1995-05 - 1995-07

Neuroscience

The Institute of Neurological Sciences and Psychiatry.

Ankara

I attended the course for microsurgery at University of Hacettepe Institute of Neurological Sciences and Psychiatry.

1998-04 - 2019-05

Observer Doctor: Neuroscience

Department of Neurosurgery, MSU - Ann Arbour, 

Michigan USA

2012-05 - 2012-05

Neuro endoscopy: Neuroscience

Ghent University - Ghent, Belgium

International endoscopic neurosurgery workshop, 

Ghent, Belgium

I attended the workshop for endoscopic skull base operations the and Neuro endoscopic third ventriculostomy at University of Ghent Hospital

Skills

Micro neurosurgery - Excellent

Neuro endoscopy - Excellent

Cranial base endoscopy - Excellent

Minimal invasive surgery - Excellent

Percutaneous spinal surgery - Excellent

Neuronavigation – Excellent

Certifications

1995-04 Microsurgery

2012-05 Endoscopy

Languages

Turkish - Native

English - Advanced

Arabic - Novice

Affiliations

Turkish Neurosurgical Society

Turkish Medical Association

Accomplishments

• Trained team of staff nurses in medical office procedures to ensure consistent quality of care.

• Published 17 articles in national and international reviews and presented papers in medical congresses.

Interests and operations I perform

Vascular diseases of brain

Endoscopic hypophysis surgery

Tumors of brain, spine and medulla spinalis surgery

Endoscopic brain ventricle surgery

Endoscopic third ventriculostomy 

Traumas of brain and spine

Cervical, thoracic and lumbar disc hernias and narrow 

canal disease surgery

Spine instrumentation and fusion surgery

Baclofen pump and neurostimulators insertions

Hydrocephalus surgery

Congenital diseases of the brain and spine (pediatric 

neurosurgery)

Peripheral nerve surgery

Dr. X has 10 years of experience in Neurosurgery at Hacettepe University Faculty of Medicine, Diskapi Yildirim Beyazit Training and Research Hospital Neurology Clinic, Yozgat City Hospital, Private Lokman Hekim Akay Hospital, and Emsey Hospital.